Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Farrar, Diane ^a   Tuffnell, D J ^b   West, J ^b  

^a BRADFORD INSTITUTE FOR HEALTH RESEARCH   (United Kingdom)

^b NONE

Author keywords

*Pregnancy in diabetics; Diabetes mellitus, type 1 *drug therapy ; Hypoglycemic agents *administration dosage ; Injections, subcutaneous; Insulin infusion systems; Insulin *administration dosage

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; NEUTRAL INSULIN; ORAL ANTIDIABETIC AGENT;

BIRTH WEIGHT; COCHRANE LIBRARY; CONTINUOUS INFUSION; DIABETES MELLITUS; FETUS MALFORMATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION PUMP; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; MACROSOMIA; MULTIPLE DRUG DOSE; PERINATAL MORTALITY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 38949112845     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005542.pub2     Document Type: Review

References (41)

1. Carta 1986 {published data only} Carta Q, Meriggi E, Trossarelli GF, Catella G, Dal Molin V, Menato G, et al.Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy [Etude comparee de la perfusion sous-cutanee continue d'insuline et de l'insulinotherapie intensive classique chez des femmes diabetiques de type I ou II enceintes]. Diabete et Metabolisme 1986;12:121-9.
2. Nosari 1993 {published data only} Nosari I, Maglio ML, Lepore G, Cortinovis F, Pagani G. Is continuous subcutaneous insulin infusion more effective than intensive conventional insulin therapy in the treatment of pregnant diabetic women?. Diabetes, Nutrition & Metabolism - Clinical & Experimental 1993;6:33-7.
3. Burkart 1988 Burkart W, Hanker JP, Schneider HPG. Complications and fetal outcome in diabetic pregnancy - Intensified conventional verses insulin pump therapy. Gynecologic and Obstetric Investigation 1988;26:104-12.
4. Collaborative 1993 Collaborative. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993;329:977-86.
5. Coustan 1986 Coustan DR, Reece A, Sherwin RS, Rudolf MCJ, Bates SE, Sockin SM, et al.A randomised clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancy. JAMA 1986;255:631-6.
6. Laatikainen 1987 Laatikainen L, Teramo K, Hieta-Heikuraninen H, Koivisto V, Pelkonen R. A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. Acta Medica Scandinavica 1987;221:367-76.
7. Zoupas 1991 Zoupas C. Insulin infusion pumps in pregnancy. Personal communication 1991.
8. Botta 1986 Botta RM, Sinarga D, Angelico MC, Bomplani GD. Intensified conventional insulin therapy as compared tomicropump therapy in pregnant women affected by type 1 diabetes mellitus [Confronto fra terapia insulinica tradizionale ottimizzata e con microinfusore in gravide affette da diabete mellito di tipo1]. Minerva Medica 1986;77:657-61.
9. Mello 2005 Mello G, Parretti E, Tondi F, Riviello C, Borri P, Scarselli G. Impact of two treatment regimens with insulin lispro in post-prandial glucose excursion patterns and fetal fat mass growth in type 1 diabetic pregnant women [abstract]. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S36.
10. Anderson 1997 Anderson JH, Brundelle RL, Koivisto VA. Reduction of postprandial hyperglycaemia and frequency of hypoglycaemia in IDDM patients on insulin analog treatment. Multicentre insulin lispro study group. Diabetes 1997;46:265-70.
11. Brink 1986 Brink SJ, Stewart C. Insulin pump treatment in insulin-dependent diabetes mellitus. JAMA 1986;255(5):617-21.
12. Buhling 2004 Buhling KJ, Kurzidim B, Wolhlfarth K, Mahmoudi M, Wascher C, Siebert G, et al.Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycaemia by comparing the self monitoring of blood glucose (SMBG) in non-pregnant women and pregnant women with impaired glucose tolerance and gestational diabetes. Experimental and Clinical Endocrinology & Diabetes 2004;112(10):556-60.
13. Casson 1997 Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah POD, et al.Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997;315:275-8.
14. CEMACH 2004 CEMACH-Royal College of Obstetricians and Gynaecologists. Maternity services in 2002 for women with type 1 and type 2 diabetes. London: CEMACH, 2004.
15. CEMACH 2005 CEMACH. Pregnancy in women with type 1 and type 2 diabetes 2002-2003. London: CEMACH, 2005.
16. Colquitt 2004 Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technology Assessment Programme 2004;8(9):43.
17. DoH 2002 Department of Health. Current and future research on diabetes: a review for the DOH and MRC. www.doh.gov.uk/nsf/diabetes/research (accessed 2002).
18. Gonzalez 2002 Gonzalez JL. Management of diabetes in pregnancy. Clinical Obstetrics and Gynecology 2002;45(1):165-9.
19. Hadden 1996 Hadden DR. The management of diabetes in pregnancy. Postgraduate Medical Journal 1996;72:525-31.
20. Hawthorne 1997 Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern diabetic pregnancy audit, 1997. BMJ 1997;315:279-81.
21. Hawthorne 2002 Hawthorne G, Modder J. Maternity services for women with diabetes in the UK. BMJ 2002;19(Suppl 4):50-5.
22. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
23. Hirsch 2005 Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, et al.Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005;28(3): 533-8.
24. Johansson 2000 Johansson UB, Adamson UC, Lins PE, Wredling RA. Improved blood glucose variability, HbA1C insuman infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicentre Lispro Insulin Study. Diabetes and Metabolism 2000;26:192-6.
25. John 1997 John WG. Glycated haemoglobin analysis. Annals of Clinical Biochemistry 1997;34:17-31.
26. Kerssen 2004 Kerssen A, De-Valk HW, Visser GHA. The continuous monitoring system during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technology & Therapeutics 2004;6(5):645-51.
27. Kilpatrick 1997 Kilpatrick ES. Problems in the assessment of glycaemic control in diabetes mellitus. Diabetic Medicine 1997;14:819-31.
28. Kilpatrick 1998 Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated haemoglobin. Diabetes Care 1998;21(2):261-4.
29. Knight 1985 Knight G, Jennings AM, Boulton AJM, Tomlinson S, Ward JD. Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. BMJ 1985;291:371-2.
30. Langer 2000 Langer O, Conway DL. Level of glycaemia and perinatal outcome in pregestational diabetes. Journal of Maternal-Fetal Medicine 2000;9:35-41.
31. Maresh 2001 Maresh M. Diabetes in pregnancy. Current Opinion in Obstetrics and Gynecology 2001;13:103-7.
32. Marshall 2000 Marshall SM, Barth JH. Standardization of HbA1c measurements-a consensus statement. Diabetic Medicine 2000;17:5-6.
33. Mecklenburg 1984 Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, et al.Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984;252(23):3265-9.
34. Pickup 2002 Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705-8.
35. Porter 2004 Porter H, Belfort MA. Evaluation of a new real-time continuous glucose monitoring system in pregnant women without gestational diabetes: a pilot study. Journal of Perinatal and Neonatal Nursing 2004;18(2):93-102.
36. RevMan 2003 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
37. Siebenhofer 2004 Siebenhofer A, Plank J, Berghold A, Horvath K, Sawicki PT, Beck P, et al.Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia 2004;47:1895-905.
38. Siebenhofer 2006 Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD003287. DOI:10.1002/ 14651858.CD003287.pub4.
39. Verheijen 2005 Verheijen ECJ, Critchley JA, Whitelaw DC, Tuffnell DJ. Outcomes of pregnancies in women with pre-existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG: an international journal of obstetrics and gynaecology 2005;112:1500-3.
40. Walkinshaw 2006 Walkinshaw SA. Very tight versus tight control for diabetes in pregnancy. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD000226. DOI:10.1002/14651858.CD000226.pub2.
41. Williams 2003 Williams J. Overview of the care of pregnantwomen with pre-existing diabetes. Journal of Diabetes Nursing 2003;7:12-6.